---
title: Our Device - Eyerising International
description: The Eyerising Myopia Management Device delivers RLRL therapy in 3-minute sessions for children aged 3-16. Non-invasive, home-use device available through optometrists and ophthalmologists.
image: https://eyerisinginternational.com/hubfs/eri-web/images/og-default.png
---

I am not an eye-care professional I am an eye-care professional

 Viewing the International site.

[![Eyerising International](https://eyerisinginternational.com/hubfs/eri-web/logo-white.png)](https://eyerisinginternational.com/?hsLang=en)

[Home](https://eyerisinginternational.com/?hsLang=en)

[About Us](https://eyerisinginternational.com/about?hsLang=en)

[About Eyerising](https://eyerisinginternational.com/about?hsLang=en) [Our Story](https://eyerisinginternational.com/story?hsLang=en) [Purpose, Mission & Values](https://eyerisinginternational.com/purpose?hsLang=en) [Our Team](https://eyerisinginternational.com/team?hsLang=en) [What is Myopia?](https://eyerisinginternational.com/myopia?hsLang=en) [Meet Willow](https://eyerisinginternational.com/willow?hsLang=en)

[Our Device](https://eyerisinginternational.com/device?hsLang=en)

[Our Device](https://eyerisinginternational.com/device?hsLang=en) [Safety Information](https://eyerisinginternational.com/safety?hsLang=en) [Regulatory](https://eyerisinginternational.com/regulatory?hsLang=en)

[News](https://eyerisinginternational.com/news?hsLang=en)

[Latest News](https://eyerisinginternational.com/news?hsLang=en) [Clinical Information](https://eyerisinginternational.com/clinical-info?hsLang=en) 

[Events](https://eyerisinginternational.com/events?hsLang=en)

[Contact](https://eyerisinginternational.com/contact?hsLang=en)

[Contact Us](https://eyerisinginternational.com/contact?hsLang=en) [Find a Clinic](https://eyerisinginternational.com/clinics?hsLang=en) [FAQs](https://eyerisinginternational.com/faqs?hsLang=en)

[Get in Touch](https://eyerisinginternational.com/contact?hsLang=en)

[Home](https://eyerisinginternational.com/?hsLang=en) [About Us](https://eyerisinginternational.com/about?hsLang=en) [Our Story](https://eyerisinginternational.com/story?hsLang=en) [Purpose, Mission & Values](https://eyerisinginternational.com/purpose?hsLang=en) [Our Team](https://eyerisinginternational.com/team?hsLang=en) [What is Myopia?](https://eyerisinginternational.com/myopia?hsLang=en) [Meet Willow](https://eyerisinginternational.com/willow?hsLang=en) [Our Device](https://eyerisinginternational.com/device?hsLang=en) [Safety Information](https://eyerisinginternational.com/safety?hsLang=en) [Regulatory Approval](https://eyerisinginternational.com/regulatory?hsLang=en) [News](https://eyerisinginternational.com/news?hsLang=en) [Clinical Information](https://eyerisinginternational.com/clinical-info?hsLang=en) [Events](https://eyerisinginternational.com/events?hsLang=en) [Contact Us](https://eyerisinginternational.com/contact?hsLang=en) [Find a Clinic](https://eyerisinginternational.com/clinics?hsLang=en) [FAQs](https://eyerisinginternational.com/faqs?hsLang=en) [Get in Touch](https://eyerisinginternational.com/contact?hsLang=en)

# The Eyerising Myopia Management Device

 A compact, non-invasive home-use device for myopia control in children aged 3–16, available exclusively through eye-care professionals. Clinical studies have reported reductions in axial elongation and slowed myopia progression.

 The Eyerising Myopia Management Device is a home-use medical device indicated for myopia control, available only through optometrists and ophthalmologists. It can help slow myopia progression by slowing the elongation of the eye and is available to children aged 3–16 years old.

## How It Works

 The device uses patented repeated low-level red-light (RLRL) technology to emit visible red light from a laser diode. This red light is delivered to the back of the eye, where it can help slow myopia progression by slowing the elongation of the eye.

 Treatment is simple enough for children to perform at home. Each session takes just three minutes, and the device records every session automatically—giving the treating clinician a clear picture of compliance and progress over time.

 The Eyerising Myopia Management Device uses patented repeated low-level red-light (RLRL) technology to emit visible red light from a laser diode. This red light is delivered to the back of the eye, where it can help slow myopia progression by slowing the elongation of the eye.

 RLRL therapy involves 3 minutes of treatment, twice a day, 5 days per week, with a minimum of 4 hours between sessions. The device is controlled via a simple touchscreen. Your child's clinician will advise which option or combination is most suitable for your child.

3 min

Per session

2×

Times a day

5

Days per week

4+ hrs

Between sessions

## Our Complete Solution

 Our solution includes three main components: The Eyerising Myopia Management Device, our secure Online System, and dedicated Customer Support.

### Online System

 Our secure online platform enables clinicians to monitor patient progress and treatment safety in real time. Compliance and session data are automatically updated, giving practitioners a clear view of treatment adherence and adverse event reporting. The system also supports communication between clinicians and families.

 Our secure online system allows your optometrist or ophthalmologist to track your child's use of the device, monitor progress, and verify safety throughout treatment. This information helps clinicians provide guidance and adjust management plans when needed.

### Myopia Management Device

 The Eyerising Myopia Management Device delivers RLRL therapy. The device is compact, non-invasive, and designed for home use under clinical supervision. It integrates into existing practice workflows and offers clinicians an additional, evidence-based option within the broader landscape of myopia management.

 The device is non-invasive and designed for use at home under the supervision of your eye-care professional. It is compact and portable, allowing children to use it comfortably in a home setting with a touch-screen interface designed for straightforward use with parental supervision.

### Customer Support

 At Eyerising International, we provide clinicians with responsive technical support, training resources, and patient guidance tools. Our dedicated support team helps ensure smooth implementation of RLRL therapy into your practice.

 Our support team works with clinicians, parents, and patients to provide reliable service, training, and assistance. This ensures families can feel supported about the device use, safety, and ongoing care.

## Clinical Evidence

### Non-invasive

Does not require drug therapy, contact lenses, or injections. Treatment is delivered as a brief session of visible red light.

### Wide Age Range

Suitable for children aged 3–16, covering the critical years when myopia typically develops and progresses fastest.

### Real-time Monitoring

Compliance data is automatically monitored and securely shared with practitioners. Published studies suggest higher adherence is associated with improved outcomes.

### Clinical Evidence

Supported by clinical studies conducted across multiple ethnicities, with outcomes reported in peer-reviewed literature.

### Safety Profile

Reinforced by post-market surveillance of patients worldwide, with no severe adverse events reported.

## Get Started

 Request a demo device and see how the Eyerising solution can work in your practice.

 Talk to your eye-care professional about the Eyerising Myopia Management Device. 

[Request a Demo Device](https://eyerisinginternational.com/contact?hsLang=en) [Find a Clinic Near You](https://eyerisinginternational.com/clinics?hsLang=en)

![Eyerising International](https://eyerisinginternational.com/hubfs/eri-web/logo-white.png)

 Advancing myopia management through repeated low-level red-light therapy.

#### Company

- [About Us](https://eyerisinginternational.com/about?hsLang=en)
- [Our Team](https://eyerisinginternational.com/team?hsLang=en)
- [Our Story](https://eyerisinginternational.com/story?hsLang=en)
- [News](https://eyerisinginternational.com/news?hsLang=en)
- [Events](https://eyerisinginternational.com/events?hsLang=en)

#### Resources

- [Our Device](https://eyerisinginternational.com/device?hsLang=en)
- [Safety Information](https://eyerisinginternational.com/safety?hsLang=en)
- [Regulatory Approval](https://eyerisinginternational.com/regulatory?hsLang=en)
- [FAQs](https://eyerisinginternational.com/faqs?hsLang=en)
- [Find a Clinic](https://eyerisinginternational.com/clinics?hsLang=en)

#### Contact

 Suite 2.05, 9/11 Claremont St  
 South Yarra VIC 3141, Australia 

[info@eyerisinginternational.com](mailto:info@eyerisinginternational.com)

[LinkedIn](https://au.linkedin.com/company/eyerising-international)

THIS PRODUCT IS NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC

ALWAYS READ THE LABEL AND FOLLOW THE DIRECTIONS FOR USE

Ask your optometrist or ophthalmologist for advice to see if this product is right for your child.

Outcomes may vary for each patient. The Eyerising Myopia Management Device is exclusively available through eye care professionals (e.g. optometrists, ophthalmologists) for home use.

© 2026 Eyerising International. All rights reserved.

[LinkedIn](https://au.linkedin.com/company/eyerising-international) [Privacy Policy](https://eyerisinginternational.com/legal?hsLang=en) [Terms & Conditions](https://eyerisinginternational.com/legal?hsLang=en)

## Welcome to Eyerising International

To show you the most relevant information, please confirm which best describes you.

I am not an Eye-Care Professional

I am an Eye-Care Professional

## Disclaimer

This website is intended for use by eye care professionals only. By agreeing and proceeding, you are declaring you are a registered eye care professional. If you are not a registered eye care professional, do not proceed.

I Agree

I Disagree

```json
{
  "@context" : "https://schema.org",
  "@type" : "MedicalOrganization",
  "address" : {
    "@type" : "PostalAddress",
    "addressCountry" : "AU",
    "addressLocality" : "South Yarra",
    "addressRegion" : "VIC",
    "postalCode" : "3141",
    "streetAddress" : "Suite 2.05, 9/11 Claremont St"
  },
  "contactPoint" : {
    "@type" : "ContactPoint",
    "contactType" : "customer service",
    "email" : "info@eyerisinginternational.com"
  },
  "description" : "Australian MedTech company advancing repeated low-level red-light (RLRL) therapy for childhood myopia management.",
  "foundingDate" : "2020",
  "logo" : "https://43619611.fs1.hubspotusercontent-ap1.net/hubfs/43619611/eri-web/logo-white.png",
  "name" : "Eyerising International",
  "sameAs" : [ "https://www.linkedin.com/company/eyerising-international" ],
  "url" : "https://eyerisinginternational.com"
}
```